Mandatory Disclosure And Cooperation To Be Proposed For Commercial Item And Overseas Contractors
Client Alert | 1 min read | 04.16.08
In a hearing before the House Oversight and Government Reform Committee on April 15, 2008, the Administrator for Federal Procurement Policy indicated that he is inclined to issue a new proposed rule that would subject commercial item contracts and contracts performed overseas to mandatory disclosure to the agency inspector general when the contractor "has reasonable grounds to believe that a principal, employee, agency, or subcontractor of the [c]ontractor has committed a violation of Federal criminal law in connection with the award or performance of [a] contract or any subcontract thereunder." Such proposed rule would also modify a November 14, 2007 proposal, discussed in the linked article by C&M's Angela Styles, to mandate "[f]ull cooperation with Government agencies responsible for audit, investigation, or corrective action" for commercial item and overseas contracts.
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
